A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS

SIMPSON, G. M., B., M., B., GH., ANGUS, J. W. S., P., F. R. C., M., D. P.·1970·Acta Psychiatrica Scandinavica

DOI 10.1111/j.1600-0447.1970.tb02066.x

Open this paper in CoChat — free account

Abstract

SUMMARY: A modification of an earlier rating scale for extrapyramidal system disturbance is described, and evidence for the validity and reliability of the scale is presented. The usefulness of the scale in studies of neuroleptic drugs is discussed. By its application it is possible to quantify extrapyramidal side effects and to separate them into four principal factors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1600-0447.1970.tb02066.x

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Items 101–153 of 153

Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety
Sheehan, D. V., McElroy, S. L., Harnett-Sheehan, K., Keck, P. E., Janavs, J., Rogers, J., Gonzalez, R., Shivakumar, G., & Suppes, T. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.10.005 · Cited by 69
Lurasidone adjunctive with lithium or valproate for bipolar depression: a placebo-controlled trial utilizing prospective and retrospective enrolment cohorts
Suppes, T., Kroger, H., Pikalov, A., & Loebel, A. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.03.012 · Cited by 65
Aripiprazole in combination with lamotrigine for the long‐term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double‐blind study (CN138‐392)
Carlson, B. X., Ketter, T. A., Sun, W., Timko, K., McQuade, R. D., Sanchez, R., Vester‐Blokland, E., & Marcus, R. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00974.x · Cited by 63
Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study
Poyurovsky, M., Epshtein, S., Fuchs, C., Schneidman, M., Weizman, R., & Weizman, A. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000084027.22282.16 · Cited by 62
Deficit in decision making in catatonic schizophrenia: An exploratory study
Bark, R., Dieckmann, S., Bogerts, B., & Northoff, G. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2004.04.013 · Cited by 62
A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia
Coppola, D., Liu, Y., Gopal, S., Remmerie, B., Samtani, M. N., Hough, D. W., Nuamah, I., Sulaiman, A., & Pandina, G. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-26 · Cited by 61
“Safety assessments included evaluation of treatmentemergent adverse events (TEAEs), extrapyramidal symptoms (EPS) rating scores based upon the Barnes Akathisia Rating Scale (BARS) [16], Simpson-Angus Rating Scale [17] (SAS), and Abnormal Involuntary Movement Scale (AIMS) [18], changes in weight, electrocardiograms, vi…”
Method
Potential effectiveness and safety of olanzapine in refractory panic disorder
Hollifield, M., Thompson, P. M., Ruiz, J. E., & Uhlenhuth, E. H. (2005) · Depression and Anxiety · doi:10.1002/da.20050 · Cited by 58
Efficacy of Intensive Cerebellar Intermittent Theta Burst Stimulation (iCiTBS) in Treatment-Resistant Schizophrenia: a Randomized Placebo-Controlled Study
Chauhan, P., Garg, S., Tikka, S. K., & Khattri, S. (2021) · The Cerebellum · doi:10.1007/s12311-020-01193-9 · Cited by 57
Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder
Calabrese, J. R., Pikalov, A., Streicher, C., Cucchiaro, J., Mao, Y., & Loebel, A. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.06.013 · Cited by 55
Effectiveness of group body psychotherapy for negative symptoms of schizophrenia: Multicentre randomised controlled trial
Priebe, S., Savill, M., Wykes, T., Bentall, R. P., Reininghaus, U., Lauber, C., Bremner, S., Eldridge, S., & Röhricht, F. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.115.171397 · Cited by 52
“23 Extrapyramidal symptoms (EPS) were evaluated at each stage using the Simpson Angus Scale (SAS), 24 however, given logistical constraints three items were not assessed (leg pendulousness, head dropping and glabella tap).”
Effects of stimulus intensity on the efficacy and safety of twice‐weekly, bilateral electroconvulsive therapy (ECT) combined with antipsychotics in acute mania: a randomised controlled trial
Mohan, T. S., Tharyan, P., Alexander, J., & Raveendran, N. S. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00668.x · Cited by 54
A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults with Schizophrenia
Forbes, A., Hobart, M., Ouyang, J., Shi, L., Pfister, S., & Hakala, M. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy002 · Cited by 52
A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in Patients with Bipolar Disorder, Mixed or Depressed Phase, and Alcohol Dependence
Brown, E. S., Davila, D., Nakamura, A., Carmody, T. J., Rush, A. J., Lo, A., Holmes, T., Adinoff, B., Caetano, R., Swann, A. C., et al. (2014) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12445 · Cited by 50
Multisite, open-label, prospective trial of lamotrigine for geriatric bipolar depression: a preliminary report
Sajatovic, M., Gildengers, A., Al Jurdi, R. K., Gyulai, L., Cassidy, K. A., Greenberg, R. L., Bruce, M. L., Mulsant, B. H., Ten Have, T., & Young, R. C. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00923.x · Cited by 49
A single‐dose, open‐label, parallel, randomized, dose‐proportionality study of paliperidone after intramuscular injections of paliperidone palmitate in the deltoid or gluteal muscle in patients with schizophrenia
Cleton, A., Rossenu, S., Crauwels, H., Berwaerts, J., Hough, D., Gopal, S., Eerdekens, M., Vandebosch, A., Remmerie, B., De Meulder, M., et al. (2014) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.295 · Cited by 48
Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia: results from the FACE-SZ dataset.
Berna, F., Misdrahi, D., Boyer, L., Aouizerate, B., Brunel, L., Capdevielle, D., Chereau, I., Danion, J. M., Dorey, J. M., Dubertret, C., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.10.040 · Cited by 47
Determining the optimal dose of haloperidol in first-episode psychosis
Oosthuizen, P., Emsley, R. A., Turner, J., & Keyter, N. (2001) · Journal of Psychopharmacology · doi:10.1177/026988110101500403 · Cited by 48
Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study
Correll, C. U., Cucchiaro, J., Silva, R., Hsu, J., Pikalov, A., & Loebel, A. (2016) · CNS Spectrums · doi:10.1017/s1092852915000917 · Cited by 48
Effectiveness of Switching to Aripiprazole From Atypical Antipsychotics in Patients With Schizophrenia
Kim, S.-W., Shin, I.-S., Kim, J.-M., Lee, J.-H., Lee, Y.-H., Yang, S.-J., & Yoon, J.-S. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31819a68b5 · Cited by 47
A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder
Young, A. H., McElroy, S. L., Olausson, B., Paulsson, B., (D1447C00001), O. B. O. T. E. I., & Embolden II (D1447C00134) Investigators (2014) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.665177 · Cited by 46
Deficits in context-dependent adaptive coding of reward in schizophrenia
Kirschner, M., Hager, O. M., Bischof, M., Hartmann-Riemer, M. N., Kluge, A., Seifritz, E., Tobler, P. N., & Kaiser, S. (2016) · npj Schizophrenia · doi:10.1038/npjschz.2016.20 · Cited by 43
Involvement of the mirror neuron system in blunted affect in schizophrenia
Lee, J. S., Chun, J. W., Yoon, S. Y., Park, H.-J., & Kim, J.-J. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2013.10.043 · Cited by 45
The structural neuroanatomy of metacognitive insight in schizophrenia and its psychopathological and neuropsychological correlates
Spalletta, G., Piras, F., Piras, F., Caltagirone, C., & Orfei, M. D. (2014) · Human Brain Mapping · doi:10.1002/hbm.22507 · Cited by 44
Effect of Adjunctive Estradiol on Schizophrenia Among Women of Childbearing Age: A Randomized Clinical Trial
Weiser, M., Levi, L., Zamora, D., Biegon, A., SanGiovanni, J. P., Davidson, M., Burshtein, S., Gonen, I., Radu, P., Slobozean Pavalache, K., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.1842 · Cited by 42
Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient
Sheehan, D. V., Harnett-Sheehan, K., Hidalgo, R. B., Janavs, J., McElroy, S. L., Amado, D., & Suppes, T. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.07.016 · Cited by 42
Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study
Bourin, M. S., Severus, E., Schronen, J. P., Gass, P., Szamosi, J., Eriksson, H., & Chandrashekar, H. (2014) · International Journal of Bipolar Disorders · doi:10.1186/s40345-014-0014-9 · Cited by 40
Effects of antipsychotics on cortisol, interleukin-6 and hippocampal perfusion in healthy volunteers
Handley, R., Mondelli, V., Zelaya, F., Marques, T., Taylor, H., Reinders, A. A. T. S., Chaddock, C., McQueen, G., Hubbard, K., Papadopoulos, A., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.03.039 · Cited by 42
“Clinical side effects, measured using the Barnes Akathisia scale (Barnes, 1989), the Simpson Angus scale (Simpson and Angus, 1970), and the Abnormal Involuntary Movement Scale (AIMS: National Institute of Mental Health), were evaluated 3 hours post intervention.”
Method
Reward-driven decision-making impairments in schizophrenia
Saperia, S., Da Silva, S., Siddiqui, I., Agid, O., Daskalakis, Z. J., Ravindran, A., Voineskos, A. N., Zakzanis, K. K., Remington, G., & Foussias, G. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2018.11.004 · Cited by 41
Switching to Antipsychotic Monotherapy vs. Staying on Antipsychotic Polypharmacy in Schizophrenia: A Systematic Review and Meta-Analysis
Matsui, K., Tokumasu, T., Takekita, Y., Inada, K., Kanazawa, T., Kishimoto, T., Takasu, S., Tani, H., Tarutani, S., Hashimoto, N., et al. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.05.030 · Cited by 41
Aripiprazole Once-Monthly 400 mg: Comparison of Pharmacokinetics, Tolerability, and Safety of Deltoid Versus Gluteal Administration
Raoufinia, A., Peters-Strickland, T., Nylander, A.-G., Baker, R. A., Eramo, A., Jin, N., Bricmont, P., Repella, J., McQuade, R. D., Hertel, P., et al. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw116 · Cited by 39
Antipsychotic Dose in Acute Schizophrenia: A Meta-analysis
Takeuchi, H., MacKenzie, N. E., Samaroo, D., Agid, O., Remington, G., & Leucht, S. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa063 · Cited by 39
Long-term efficacy of quetiapine in combination with lithium or divalproex on mixed symptoms in bipolar I disorder
Vieta, E., Suppes, T., Ekholm, B., Udd, M., & Gustafsson, U. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.04.014 · Cited by 37
Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate
J�rgensen, A., Andersen, J., Bj�rndal, N., Dencker, S. J., Lundin, L., & Malm, U. (1982) · Psychopharmacology · doi:10.1007/bf00436100 · Cited by 36
Six-Month Outcomes From a Randomized Trial Augmenting Serotonin Reuptake Inhibitors With Exposure and Response Prevention or Risperidone in Adults With Obsessive-Compulsive Disorder
Foa, E. B., Simpson, H. B., Rosenfield, D., Liebowitz, M. R., Cahill, S. P., Huppert, J. D., Bender Jr, J., McLean, C. P., Maher, M. J., Campeas, R., et al. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09044 · Cited by 34
Zolmitriptan compared to propranolol in the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study.
Avital, A., Gross-Isseroff, R., Stryjer, R., Hermesh, H., Weizman, A., & Shiloh, R. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.02.006 · Cited by 33
An exploratory, open-label, randomized trial comparing risperidone long-acting injectable with oral antipsychotic medication in the treatment of early psychosis.
Malla, A., Chue, P., Jordan, G., Stip, E., Koczerginski, D., Milliken, H., Joseph, A., Williams, R., Adams, B., Manchanda, R., et al. (2016) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.mach.061213 · Cited by 30
High-Dose Olanzapine for Treatment-Refractory Schizophrenia
Lerner, V. (2003) · Clinical Neuropharmacology · doi:10.1097/00002826-200303000-00003 · Cited by 29
Long-Acting Injectable Second-Generation Antipsychotics vs Placebo and Their Oral Formulations in Acute Schizophrenia: A Systematic Review and Meta-Analysis of Randomized-Controlled-Trials
Wang, D., Schneider-Thoma, J., Siafis, S., Burschinski, A., Dong, S., Wu, H., Zhu, Y., Davis, J. M., Priller, J., & Leucht, S. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad089 · Cited by 29
Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial
Freund-Levi, Y., Jedenius, E., Tysen-Bäckström, A. C., Lärksäter, M., Wahlund, L.-O., & Eriksdotter, M. (2014) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.05.005 · Cited by 28
Premorbid, clinical and cognitive correlates of primary negative symptoms in first-episode psychosis
Chang, W. C., Lau, C. F. C., Chan, S. S. I., Hui, C. L. M., Chan, S. K. W., Lee, E. H. M., Lin, J., & Chen, E. Y. H. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.05.045 · Cited by 29
Inpatients with schizophrenia report impaired situational motivation but intact global and social motivation
Trémeau, F., Goldman, J., Antonius, D., & Javitt, D. C. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.05.031 · Cited by 28
The burden of depressive symptoms in people with schizophrenia
Conley, R. R. (2009) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.09.001 · Cited by 28
Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania
McElroy, S. L., Martens, B. E., Winstanley, E. L., Creech, R., Malhotra, S., & Keck (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.11.014 · Cited by 27
Pharmacokinetic profile after multiple deltoid or gluteal intramuscular injections of paliperidone palmitate in patients with schizophrenia
Rossenu, S., Cleton, A., Hough, D., Crauwels, H., Vandebosch, A., Berwaerts, J., Eerdekens, M., Herben, V., De Meulder, M., Remmerie, B., et al. (2015) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.144 · Cited by 26
Effectiveness of targeted intervention and maintenance pharmacotherapy in conjunction with family intervention in schizophrenia
Wiedemann, G., Hahlweg, K., Müller, U., Feinstein, E., Hank, G., & Dose, M. (2001) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060170056 · Cited by 23
Model-Guided Antipsychotic Dose Reduction in Schizophrenia: A Pilot, Single-Blind Randomized Controlled Trial
Ozawa, C., Bies, R. R., Pillai, N., Suzuki, T., Mimura, M., & Uchida, H. (2019) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001046 · Cited by 18
Combination therapy with amisulpride and antidepressants: Clinical observations in case series of elderly patients with psychotic depression
Politis, A. M., Papadimitriou, G. N., Theleritis, C. G., Psarros, C., & Soldatos, C. R. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.03.011 · Cited by 15
Adjunctive brexpiprazole for elderly patients with major depressive disorder: An open‐label, long‐term safety and tolerability study
Lepola, U., Hefting, N., Zhang, D., & Hobart, M. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4952 · Cited by 15
Challenging the Need for Sustained Blockade of Dopamine D2 Receptor Estimated From Antipsychotic Plasma Levels in the Maintenance Treatment of Schizophrenia: A Single-Blind, Randomized, Controlled Study
Tsuboi, T., Suzuki, T., Bies, R. R., Remington, G., Pollock, B. G., Mimura, M., & Uchida, H. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.03.025 · Cited by 13
What can the study of first impressions tell us about attitudinal ambivalence and paranoia in schizophrenia
Trémeau, F., Antonius, D., Todorov, A., Rebani, Y., Ferrari, K., Lee, S. H., Calderone, D., Nolan, K. A., Butler, P., Malaspina, D., et al. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.02.014 · Cited by 12
Gradual vs. wait-and-gradual discontinuation in antipsychotic switching: A meta-analysis
Takeuchi, H., Thiyanavadivel, S., Agid, O., & Remington, G. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.02.011 · Cited by 12
The effect of therapeutic drug monitoring of risperidone and aripiprazole on weight gain in children and adolescents: the SPACe 2: STAR (trial) protocol of an international multicentre randomised controlled trial
Hermans, R. A., Ringeling, L. T., Liang, K., Kloosterboer, S. M., de Winter, B. C. M., Hillegers, M. H. J., Koch, B. C. P., & Dierckx, B. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04445-6 · Cited by 10
Pharmacokinetic and pharmacodynamic studies on high doses of fluphenazine
Dencker, S. J., Johansson, R., & Malm, U. (1988) · Psychopharmacology · doi:10.1007/bf00176852 · Cited by 7

Authors: SIMPSON, G. M., B., M., B., G., ANGUS, J. W. S., P., F. R. C., & M., D. P.
Venue: Acta Psychiatrica Scandinavica
Publisher: Wiley
Published: 1970-03
Volume: 45
Issue: S212
Pages: 11-19
ISSN: 0001-690X (ISSN-L)
1600-0447
DOI: 10.1111/j.1600-0447.1970.tb02066.x
OpenAlex: W2165379748
Cited by: 3,264
References: 0
FWCI: 10.72
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 13689 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cited by

Metadata

Record

About these checks

Data sources